Latest Advances

  • Condition: Chronic Lymphocytic Leukemia
  • Journal: Drug design, development and therapy
  • Treatment Used: Zanubrutinib
  • Number of Patients: NULL
  • Published —
The study researched the use of Zanubrutinib for treating chronic lymphocytic leukemia.
  • Condition: B Cell Malignancies
  • Journal: Journal of hematology & oncology
  • Treatment Used: Non-Covalent BTK Inhibitors
  • Number of Patients: 0
  • Published —
This study discusses the use of non-covalent Bruton tyrosine kinase (BTK) inhibitors in the treatment of patients with B cell malignancies.
  • Condition: Relapsed or Refractory B-Cell Malignancies
  • Journal: Lancet (London, England)
  • Treatment Used: Pirtobrutinib
  • Number of Patients: 323
  • Published —
This study evaluated the safety and effectiveness of pirtobrutinib in the treatment of patients with relapsed or refractory B-cell malignancies.
  • Condition: Chronic Lymphocytic Leukemia (CLL)
  • Journal: Orvosi hetilap
  • Treatment Used: Ibrutinib and Venetoclax
  • Number of Patients: 0
  • Published —
This article discusses the treatment of patients with chronic lymphocytic leukemia (CLL).
  • Condition: Chronic Lymphocytic Leukemia
  • Journal: Current oncology (Toronto, Ont.)
  • Treatment Used: Acalabrutinib
  • Number of Patients: 1
  • Published —
The study researched the treatment of a patient with chronic lymphocytic leukemia.
  • Condition: Paronychia and Granulation with Chronic Lymphocytic Leukemia
  • Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
  • Treatment Used: Silver Nitrate Chemical Cauterization with Ibrutinib Therapy
  • Number of Patients: 1
  • Published —
This case report describes a patient with paronychia and granulation that is undergoing ibrutinib therapy for chronic lymphocytic leukemia.
  • Condition: Chronic Myeloid Leukemia (CML)
  • Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
  • Treatment Used: Dasatinib
  • Number of Patients: 280
  • Published —
This study explored dasatinib-related pulmonary (lung) events in patients with chronic myeloid leukemia (cancer of the white blood cells; CML).
  • Condition: Children with Chronic Hepatitis B in Remission of Acute Lymphoblastic Leukemia
  • Journal: Georgian medical news
  • Treatment Used: Betargin
  • Number of Patients: 41
  • Published —
The purpose of the study is to assess the effectiveness of Betargin in complex management of patients with chronic hepatitis B in remission of acute lymphoblastic leukemia.
  • Condition: Chronic Lymphocytic Leukemia
  • Journal: Current oncology (Toronto, Ont.)
  • Treatment Used: Bruton Tyrosine Kinase Inhibitors
  • Number of Patients: NULL
  • Published —
The study researched the outcomes of bruton tyrosine kinase inhibitors for treating chronic lymphocytic leukemia.
  • Condition: Chronic Lymphocytic Leukemia
  • Journal: Cells
  • Treatment Used: Low Dose rIL-2 with Lenalidomide or Venetoclax
  • Number of Patients: NULL
  • Published —
The study researched the outcomes of low dose rIL-2 in combination with either lenalidomide or venetoclax in treating chronic lymphocytic leukemia.
  • Condition: Autoimmune Cytopenia
  • Journal: Experimental oncology
  • Treatment Used: Various
  • Number of Patients: 83
  • Published —
In this study, researchers sought to determine the best treatment for autoimmune cytopenia due to chronic lymphocytic leukemia.
Showing 1-12 of 190